GlassScriptPhysician profile
Michael Shannon Todd
NPI 1922158997
$12,113.90
in general payments reported to CMS, 2019-2025
16 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,882 · 2020: $565 · 2021: $2,372 · 2022: $393 · 2023: $1,804 · 2024: $716 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,731 · Travel and Lodging: $1,072 · Education: $99.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,731.14 |
| Travel and Lodging | $1,071.73 |
| Education | $99.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,053.51 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Crossroads Orthopedics, LLC | $2,254.98 | 2019-2021 | |
| Arthrex, INC. | $1,097.57 | 2019 | |
| Zimmer Biomet Holdings, INC. | $223.52 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Acumed LLC | $125.00 | 2019 | |
| Smith+Nephew, INC. | $71.86 | 2019 | |
| Amgen INC. | $65.08 | 2022-2023 | Prolia, Evenity |
| Catalyst Orthoscience | $59.84 | 2025 | |
| Ethicon US, LLC | $41.82 | 2022 | |
| Djo, LLC | $23.89 | 2024 | Cmf |
| Mf Med | $22.05 | 2024 | |
| Davol INC. | $18.26 | 2023 | Arista Ah Flexitip |
| Kowa Pharmaceuticals America, INC. | $15.66 | 2022 | |
| Boston Scientific Corporation | $14.88 | 2025 | General - Pain Management |
| Linvatec Corporation | $13.99 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.